Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
4.870
+0.030 (0.62%)
At close: Sep 4, 2026, 4:00 PM EDT
4.930
+0.060 (1.23%)
After-hours: Sep 4, 2026, 7:09 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $923.25 million as of September 4, 2026. Its market cap has increased by 309.85% in one year.
Market Cap
923.25M
Enterprise Value
738.66M
1-Year Change
309.85%
Ranking
Category
Stock Price
$4.87
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $923.25M, an increase of 44.37%. That is a compound annual growth rate of 6.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 923.25M | 23.39% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye Group | 966.61M |
| Wave Life Sciences | 957.65M |
| Design Therapeutics | 947.49M |
| Ardelyx | 941.93M |
| Olema Pharmaceuticals | 940.60M |
| Rigel Pharmaceuticals | 909.15M |
| Aclaris Therapeutics | 908.22M |
| Crescent Biopharma | 893.69M |